EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Docosahexaenoic acid supplementation in pregnancy and early lactation: Impacts on breast milk docosahexaenoic acid and Maternal–Infant gut microbiota – A randomized controlled trial

Tingchao He, Jian Zhang, Ai Zhao, Sha Luo, Hua Jiang, Minghua Tang, Yumei Zhang

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.09.006 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Tingchao He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Milk, Human, Gastrointestinal Microbiome, Dietary Supplements. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aimed to evaluate whether docosahexaenoic acid (DHA) supplementation during pregnancy increases DHA concentrations in colostrum among Chinese women, and to determine whether continued postpartum supplementation is necessary to sustain DHA levels throughout lactation. Additionally, the study examined the impact of maternal DHA supplementation on the gut microbiota of both mothers and their infants. METHODS: 79 pregnant women were enrolled in this multicenter, double-blinded, randomized, placebo-controlled, parallel trial and were randomized to three groups (CC, control group; FC, DHA supplementation in the third trimester; FF, DHA supplementation from the third trimester to 42 days postpartum). Participants in the FF and FC groups were administered 100 mg/day DHA via milk powder and those in the CC group were administered milk powder without DHA fortification. Breast milk was collected - on days 3 and 42 postpartum. Fatty acid composition in breast milk was measured with gas chromatography and expressed as percentage of total fatty acids by weight. Fecal samples from mothers (at gestational week 28, 38 and 42 days postpartum) and infants (at 3 and 42 days of age) were collected, then analyzed using 16S rRNA sequencing. RESULTS: The FF group had significantly higher levels of DHA in colostrum than the other two groups (FF: 1.49%, FC: 1.27%, CC: 1.11, P-ANCOVA = 0.018) but not in early mature milk (FF: 0.94%, FC: 0.82%, CC: 0.85%, P-ANCOVA = 0.646). At 42 days postpartum, both mothers and infants in the FF group exhibited a higher abundance of the genus Lactobacillus in the fecal microbiome. CONCLUSION: In this cohort of Chinese women, maternal supplementation with 100 mg/day of DHA starting from the third trimester of pregnancy significantly increased DHA concentrations in colostrum. However, 100 mg/day may be insufficient to sustain DHA levels beyond colostrum. Additionally, maternal DHA supplementation was found to influence Lactobacillus abundance at 42 days postpartum of both mothers and their infants. Future studies should explore higher DHA doses for long-term lactation stability, and investigate dynamic changes in other gut microbiota taxa and microbiota-mediated health effects. CLINICAL TRIAL REGISTRATION: ChinaClinicalTrial.gov (ChiCTR1800019461).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsMilk, HumanGastrointestinal MicrobiomeDietary SupplementsLactationHumansFemalePregnancyDouble-Blind MethodAdultColostrumInfant, NewbornInfantMaternal Nutritional Physiological PhenomenaFecesChinaPostpartum Period

Stichwörter der Autor:innen

16s rRNA sequencingDocosahexaenoic acidGut microbiotaHuman breast milkLactationPregnancy

Substanzen

Docosahexaenoic Acids

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China; Vanke School of Public Health, Tsinghua University, Beijing 100084, China.
  • Maternal and Child Health Hospital of Changsha County, Changsha City 410100, Hunan province, China.
  • School of Nursing, Peking University, Beijing 100091, China.
  • Department of Food Science and Human Nutrition, Colorado State University, Fort Collins, CO 80521, USA.
  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Electronic address: zhangyumei@bjmu.edu.cn.

Zitieren

APA

He, T., Zhang, J., Zhao, A., Luo, S., Jiang, H., Tang, M., & Zhang, Y. (2025). Docosahexaenoic acid supplementation in pregnancy and early lactation: Impacts on breast milk docosahexaenoic acid and Maternal–Infant gut microbiota – A randomized controlled trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.09.006

Vancouver

He T, Zhang J, Zhao A, Luo S, Jiang H, Tang M, et al. Docosahexaenoic acid supplementation in pregnancy and early lactation: Impacts on breast milk docosahexaenoic acid and Maternal–Infant gut microbiota – A randomized controlled trial. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.09.006

BibTeX
@article{He2025,
  author = {He, Tingchao and Zhang, Jian and Zhao, Ai and Luo, Sha and Jiang, Hua and Tang, Minghua and Zhang, Yumei},
  title = {Docosahexaenoic acid supplementation in pregnancy and early lactation: Impacts on breast milk docosahexaenoic acid and Maternal–Infant gut microbiota – A randomized controlled trial},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.09.006}
}
Kostenlos starten →